XPH Holdings: State Street SPDR S&P Pharmaceuticals Top Holdings
NYSEARCA: XPHState Street Investment ManagementHealthETFUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
XPH portfolio concentration
The State Street SPDR S&P Pharmaceuticals ETF (XPH) reports 10 holdings. Its biggest position is Xeris Biopharma Holdings Inc (XERS) at 2.46% of assets. The top 10 holdings account for 21.7% of the portfolio, a broadly diversified portfolio.
10 positions carry a weight of 1% or more. Based on the weights listed, XPH behaves like an equal-weighted fund of about 211 stocks (the inverse Herfindahl index), a measure of how diversified it really is. Holdings and weights change over time as the fund rebalances and as share prices move.
Click any ticker to see that company's stock price, financials and news.
Summary generated from market data by MetaCap's automated system. Methodology
XPH holdings by weight
| # | Holding | Weight |
|---|---|---|
| 1 | XERSXeris Biopharma Holdings Inc | 2.46% |
| 2 | MANEVeradermics Inc | 2.42% |
| 3 | AMRXAmneal Pharmaceuticals Inc Ordinary Shares - Class A | 2.32% |
| 4 | LGNDLigand Pharmaceuticals Inc | 2.15% |
| 5 | VTRSViatris Inc | 2.13% |
| 6 | INDVIndivior Pharmaceuticals Inc Ordinary Share | 2.05% |
| 7 | PRGOPerrigo Co PLC | 2.05% |
| 8 | LLYEli Lilly and Co | 2.04% |
| 9 | ANIPANI Pharmaceuticals Inc | 2.04% |
| 10 | PFEPfizer Inc | 2.04% |